The Consumer Healthcare Products Association and the other members of the Health Choices Coalition on Friday sent letters to members of Congress urging the repeal of the requirement that prevents consumers from using their flexible spending arrangements to purchase over-the-counter medicines without first getting a doctor’s prescription.
GlaxoSmithKline on Thursday morning presented exactly how technology might improve appropriate patient self-selection before a panel convened by the Food and Drug Administration to explore expanding the prescripton-to-over-the-counter switch paradigm by incorporating technology and/or pharmacy participation in the application process.
NACDS RxImpact Day on Capitol Hill showcased the unsurpassed value of community pharmacy as pharmacy advocates from 41 states conducted more than 350 meetings with U.S. senators and representatives this week.
More than 5.1 million seniors and people with disabilities on Medicare saved billions on prescription drugs, thanks to the Patient Protection and Affordable Care Act, according to Department of Health and Human Services secretary Kathleen Sebelius.
DSN's Pharmacy Technology Report takes a look at the hottest technology in the health-and-wellness space and where investors are looking to take health IT in the future. Also included is DSN's exclusive roundtable discussion with leading pharmacy retailers and executives from leading and emerging healthcare technology companies, which included new technologies to improve compliance, self-care and pharmacist-patient interactions.
There is power in information. There is even more power in that information when it is conveniently available at the precise moment it is needed — in this case, during one of a patient's increasingly time-crunched appointments with a general healthcare practitioner.
A new partnership aims to educate pharmacists, other healthcare professionals, caregivers and patients about diabetes and about how pharmacists can work with physicians to help patients manage the condition.
In excess of $102 billion. That's the value over-the-counter medicine delivers to the U.S. healthcare system, Consumer Healthcare Products Association leaders shared with attendees of the CHPA Annual Executive Conference held here Friday morning.
Written testimony submitted by the National Association of Chain Drug Stores underscored chain pharmacies’ commitment to patient safety as part of the next Prescription Drug User Fee Act reauthorization, and emphasized that community pharmacist-provided services help improve health outcomes without the introduction of unproven technologies.
In January, specialty pharmacy group contracting organization Armada Health Care introduced ApproveRx, a Web-based system that it says will greatly streamline the prior authorization process and already has been adopted by Amber Pharmacy. Meanwhile, the company also is gearing up for the Armada Summit at the Wynn Las Vegas Hotel in May.
Patients in Canada increasingly are tapping into the healthcare knowledge, expertise and services available at their local pharmacy, with many of them talking to their pharmacist about one or more healthcare issues other than filling a prescription, according to the findings of a new Nielsen survey commissioned by the Canadian Association of Chain Drug Stores.
There is one key takeaway from Fast Company's naming of Walgreens as one of the industry's most innovative companies — Walgreens wasn't classified under the industry banner of "retailer," but under the industry banner of "health care."
The National Association of Chain Drug Stores on Tuesday expressed support for H.R. 4095, “The Online Pharmacy Safety Act,” which the organization said will help consumers protect themselves against the growing threat of illegitimate online drug sellers.
About $290 billion a year. That’s what Americans’ rampant nonadherence to their prescription medication therapy is costing the country each year in medical bills and lost work, according to national estimates. So getting patients to stick with their drug regimens is a huge challenge, not only for pharmacists in all practice settings, but for the entire healthcare provider network and the U.S. economy.
The Food and Drug Administration on Tuesday announced it will hold a public hearing on March 22 and 23 to discuss how technology can expand which drug products can be switched from prescription to over-the-counter status.